Medvi, a GLP-1 telehealth provider, has emerged as a significant player in the healthcare sector since its inception in September 2024. Founded by Matthew Gallagher with an initial investment of just $20,000, the company has utilized over a dozen AI tools, including ChatGPT, Claude, and Grok, to streamline operations and enhance service delivery.
By the end of 2025, Medvi reported sales of $401 million and boasted a customer base of 250,000. This remarkable growth trajectory aligns with predictions made by OpenAI CEO Sam Altman, who suggested that AI could empower individuals to create billion-dollar companies.
Gallagher’s innovative approach has not gone unnoticed. “Growth was insane,” he remarked, reflecting on the company’s rapid expansion. The company’s net profit margin stood at 16.2% in 2025, showcasing its financial viability.
In February 2026, Medvi launched a men’s health line, which quickly gained traction, attracting 50,000 customers in its first month. This swift uptake indicates a strong market demand for telehealth services tailored to men’s health needs.
Industry observers are keenly watching Medvi’s progress, especially as the company is projected to reach $1.8 billion in sales by the end of 2026. This projection underscores the growing acceptance and reliance on telehealth solutions in the healthcare landscape.
Gallagher’s brother, Elliot, serves as the company’s sole employee, highlighting the ultra-lean structure that has become a hallmark of Medvi’s operation. This model exemplifies the potential for AI to enable hyper-scalable companies, as noted by industry analysts.
As Medvi continues to expand its offerings and customer base, key figures in the healthcare and technology sectors are taking note of its success. Jon Lensing, an industry expert, commented, “Matthew’s native tongue seems to be A.I.,” emphasizing Gallagher’s adeptness at leveraging technology for business growth.
With the telehealth market evolving rapidly, Medvi’s innovative strategies and impressive growth metrics position it as a leader in the field. Observers anticipate that the company will continue to set benchmarks for success in the telehealth industry.
Details remain unconfirmed regarding future expansions or additional product lines, but the current trajectory suggests that Medvi will remain a significant force in the healthcare market.